Last update 01 Nov 2024
Liraglutide biosimilar(Sciwind Biosciences/Etinpro)
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Recombinant polypeptide, Biosimilar |
Synonyms- |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Gene Sequence
Sequence Code 50953
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Liraglutide biosimilar(Sciwind Biosciences/Etinpro)比对试验药利拉鲁肽注射液与对照药诺和力®在中国健康男性受试者中的药代动力学及安全性的Ⅰ期临床研究
[Translation] Phase I clinical study comparing the pharmacokinetics and safety of the experimental drug liraglutide injection and the control drug Victoza® in healthy male subjects in China
100 Clinical Results associated with Liraglutide biosimilar(Sciwind Biosciences/Etinpro)
Login to view more data
100 Translational Medicine associated with Liraglutide biosimilar(Sciwind Biosciences/Etinpro)
Login to view more data
100 Patents (Medical) associated with Liraglutide biosimilar(Sciwind Biosciences/Etinpro)
Login to view more data
100 Deals associated with Liraglutide biosimilar(Sciwind Biosciences/Etinpro)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | CN | 01 Mar 2018 | |
| Diabetes Mellitus, Type 2 | Preclinical | CN | 01 Mar 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free